Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skin Laboratory PCLBKK:SKIN +3.53%20 Altman Z-Score is 5.92 as of Aug. 19, 2026, which is 26% below its 10-year median of 8.02. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,933 Consumer Packaged Goods companies, Skin Laboratory PCL ranks better than 80.44% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 5.88 is strong.
Skin Laboratory PCL has a Altman Z-Score of 5.92, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Skin Laboratory PCL's Altman Z-Score or its related term are showing as below:
BKK:SKIN'
s Altman Z-Score Range Over the Past 10 Years
Min: 5.88 Med: 8.02 Max: 19.81
Current: 5.88
During the past 4 years, Skin Laboratory PCL's highest Altman Z-Score was 19.81. The lowest was 5.88. And the median was 8.02.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Skin Laboratory PCL Altman Z-Score Related Terms
Skin Laboratory PCL Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Skin Laboratory PCL's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SKIN vs PG, CL, KVUE: Altman Z-Score Comparison
For the Household & Personal Products subindustry, Skin Laboratory PCL's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skin Laboratory PCL Altman Z-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Skin Laboratory PCL's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Skin Laboratory PCL's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.8
+
1.4
*
-0.0683
+
3.3
*
-0.0506
+
0.6
*
6.2748
+
1.0
*
1.4607
=
5.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Skin Laboratory PCL (BKK:SKIN) has a Altman Z-Score of 5.92 as of Aug. 19, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Skin Laboratory PCL and its competitors. This is 26% below median its historical median of 8.02. Over the past decade, Skin Laboratory PCL's Altman Z-Score has ranged from 5.88 to 19.81. According to the industry distribution chart, Skin Laboratory PCL ranks #378 out of 1933 companies in the Consumer Packaged Goods industry, placing it in the top 19.6%.
Is Skin Laboratory PCL's Altman Z-Score too high?
Skin Laboratory PCL's current Altman Z-Score of 5.92 is 26% below median its 10-year median of 8.02. Over the past 10 years, this metric has ranged from a low of 5.88 to a high of 19.81. The Consumer Packaged Goods industry median Altman Z-Score is 2.91. Skin Laboratory PCL's value of 5.92 is 103.4% above this industry median. Based on the distribution chart, Skin Laboratory PCL ranks #378 out of 1933 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's Altman Z-Score compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Skin Laboratory PCL ranks #378 out of 1933 companies for Altman Z-Score. This places Skin Laboratory PCL in the top 20% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.91. Skin Laboratory PCL's value of 5.92 is 103.4% above this benchmark. Historically, Skin Laboratory PCL's own Altman Z-Score has ranged from 5.88 to 19.81 over the past decade. While the company's 10-year median is 8.02 vs. the industry median of 2.91, Skin Laboratory PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Consumer Packaged Goods company?
The median Altman Z-Score among Consumer Packaged Goods companies is 2.91, based on 1,933 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Skin Laboratory PCL's current Altman Z-Score of 5.92 is 103.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Skin Laboratory PCL and its competitors. For the Consumer Packaged Goods industry, the median Altman Z-Score is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skin Laboratory PCL's current Altman Z-Score is 5.92, which is 26% below median its own 10-year median of 8.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current Altman Z-Score of 5.92. The current Altman Z-Score is 5.92, which is 26% below median its 10-year median of 8.02 and 103.4% above the Consumer Packaged Goods industry median of 2.91. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current Altman Z-Score is 5.92 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score
Get the complete analysis for BKK:SKIN
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKIN has been successfully added to your 
